$BMRN BIOMARIN PHARMACEUTICAL INC Insider Trading Week 16/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC in week 16/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 82.15 | 11,059 | 908,497 | 62,543 | 73.6 K to 62.5 K (-15.03 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 112,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 122,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.29 | 10,000 | 822,887 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.58 | 10,000 | 825,811 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 82.15 | 11,059 | 908,497 | 62,543 | 73.6 K to 62.5 K (-15.03 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 112,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 122,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.29 | 10,000 | 822,887 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.58 | 10,000 | 825,811 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 132,500 | |
| Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.65 | 10,000 | 836,458 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |